Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CKD BIO CORPORATION

Home Clinical Trial Sponsors and OrganizationsCKD BIO CORPORATION

CKD BIO CORPORATION

VIA GIOTTO 26, Milano, Italy

Also known as:

ckd bio corp. ansan factory

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

5

0 active

Approvals

4

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

3

60.0%

Not Applicable

1

20.0%

Phase 3

1

20.0%

Trial Status Distribution

Completed

4

80.0%

Recruiting

1

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease

Feb 202660 participants

Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial

Apr 2023300 participants

Safety and Efficacy of CKDB-501B in Subjects With Moderate-to-severe Glabellar Lines

Jun 202230 participants

Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb Spasticity

Jun 202224 participants

Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines

Feb 202230 participants

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

4

Approvals

Recent Approvals

Clavulanate Potassium-Silicon Dioxide

Clavulanate Potassium-Silicon Dioxide

News

No news articles found

On this page

Overview
Clinical Trials5
Approvals4
News

Back to Organizations